BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 628787)

  • 1. A catalytic generator for the production of H2 14O and H2 15O.
    Nickles RJ; Kiuru AJ; Schuster SM; Holden JE
    Prog Nucl Med; 1978; 4():72-9. PubMed ID: 628787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of [15O]water at low-energy proton cyclotrons.
    Powell J; O'Neil JP
    Appl Radiat Isot; 2006 Jul; 64(7):755-9. PubMed ID: 16617023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem Van de Graaff accelerator production of positron labeled radiopharmaceuticals for routine clinical use.
    Jones SC; Robinson GD; McIntyre E
    Int J Appl Radiat Isot; 1984 Aug; 35(8):721-9. PubMed ID: 6332785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclides and radiopharmaceuticals at Mount Sinai Medical Center.
    Finn RD
    Prog Nucl Med; 1978; 4():108-12. PubMed ID: 628767
    [No Abstract]   [Full Text] [Related]  

  • 5. Design of a target system for producing clinically useful quantities of oxygen-15 using an electron linear accelerator.
    Piltingsrud HV
    Med Phys; 1982; 9(4):514-20. PubMed ID: 7110082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and dosimetry of [14O]water for PET activation studies.
    Sajjad M; Zaini MR; Liow JS; Rottenberg DA; Strother SC
    Appl Radiat Isot; 2002 Nov; 57(5):607-15. PubMed ID: 12433034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radioisotope production program at the 76-inch Crocker Nuclear Laboratory's isochronous cyclotron.
    Lagunas-Solar MC
    Prog Nucl Med; 1978; 4():118-28. PubMed ID: 628769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of an automatic synthesis system for cyclotron--produced radiopharmaceuticals: 15O-water and 11C-cyanide].
    Nishihara Y; Tanaka A; Enoki K; Saji H; Torizuka K
    Radioisotopes; 1984 Oct; 33(10):706-9. PubMed ID: 6522649
    [No Abstract]   [Full Text] [Related]  

  • 9. A routine, automated synthesis of oxygen-15-labeled butanol for positron tomography.
    Berridge MS; Cassidy EH; Terris AH
    J Nucl Med; 1990 Oct; 31(10):1727-31. PubMed ID: 2213199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Air activation produced by high-energy medical accelerators.
    McGinley PH; White TA
    Med Phys; 1983; 10(6):796-800. PubMed ID: 6656693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote processing, delivery and injection of H2[15O] produced from a N2/H2 gas target using a simple and compact apparatus.
    Ferrieri RA; Alexoff DL; Schlyer DJ; Wolf AP
    Appl Radiat Isot; 1994 Dec; 45(12):1149-54. PubMed ID: 7894394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclotron-related radiopharmaceutical development program at UCLA.
    Robinson GD
    Prog Nucl Med; 1978; 4():80-92. PubMed ID: 628788
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.
    Ng CS; Kodama Y; Mullani NA; Barron BJ; Wei W; Herbst RS; Abbruzzese JL; Charnsangavej C
    J Comput Assist Tomogr; 2009; 33(3):460-5. PubMed ID: 19478644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent chemical compositions of 13N and 15O induced in air by the operation of a high energy electron accelerator.
    Endo A; Henshaw J; Mignanelli MA
    Health Phys; 1998 Apr; 74(4):456-64. PubMed ID: 9525420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anhydrous F-18 labeled eslemental flurine for radiopharmaceutical preparation.
    Casella V; Ido T; Wolf AP; Fowler JS; MacGregor RR; Ruth TJ
    J Nucl Med; 1980 Aug; 21(8):750-7. PubMed ID: 7400831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
    Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
    J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation absorbed dose estimates for oxygen-15 radiopharmaceuticals (H2(15)O, C15O, O15O) in newborn infants.
    Powers WJ; Stabin M; Howse D; Eichling JO; Herscovitch P
    J Nucl Med; 1988 Dec; 29(12):1961-70. PubMed ID: 3193210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Clinac-35 for tissue activation in noninvasive measurement of capillary blood flow.
    Nussbaum GH; Purdy JA; Granda CO; Emami B; Sapareto SA
    Med Phys; 1983; 10(4):487-90. PubMed ID: 6888364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation.
    Iida H; Takahashi A; Tamura Y; Ono Y; Lammertsma AA
    J Nucl Med; 1995 Jan; 36(1):78-85. PubMed ID: 7799088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.